A detailed history of Bank Of America Corp transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Bank Of America Corp holds 275,076 shares of WVE stock, worth $3.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
275,076
Previous 75,073 266.41%
Holding current value
$3.72 Million
Previous $374,000 502.94%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.12 - $9.01 $1.02 Million - $1.8 Million
200,003 Added 266.41%
275,076 $2.26 Million
Q2 2024

Aug 14, 2024

SELL
$4.38 - $6.48 $80,648 - $119,316
-18,413 Reduced 19.7%
75,073 $374,000
Q1 2024

May 15, 2024

BUY
$3.54 - $6.84 $110,660 - $213,818
31,260 Added 50.24%
93,486 $576,000
Q4 2023

Feb 14, 2024

BUY
$4.16 - $6.87 $23,146 - $38,224
5,564 Added 9.82%
62,226 $314,000
Q2 2023

Aug 14, 2023

SELL
$3.51 - $4.69 $1.82 Million - $2.43 Million
-518,716 Reduced 90.15%
56,662 $206,000
Q1 2023

May 12, 2023

BUY
$3.58 - $6.3 $1.83 Million - $3.22 Million
510,320 Added 784.41%
575,378 $2.49 Million
Q4 2022

Feb 10, 2023

BUY
$3.18 - $7.0 $110,005 - $242,151
34,593 Added 113.55%
65,058 $455,000
Q3 2022

Nov 14, 2022

BUY
$2.37 - $4.28 $21,870 - $39,495
9,228 Added 43.45%
30,465 $110,000
Q2 2022

Aug 12, 2022

BUY
$1.23 - $3.25 $11,450 - $30,254
9,309 Added 78.04%
21,237 $69,000
Q1 2022

May 16, 2022

SELL
$2.0 - $3.28 $22,132 - $36,296
-11,066 Reduced 48.13%
11,928 $24,000
Q4 2021

Feb 08, 2022

BUY
$3.14 - $5.15 $7,843 - $12,864
2,498 Added 12.19%
22,994 $73,000
Q3 2021

Nov 15, 2021

BUY
$4.89 - $7.12 $16,772 - $24,421
3,430 Added 20.1%
20,496 $100,000
Q2 2021

Sep 13, 2021

BUY
$5.65 - $7.47 $96,422 - $127,483
17,066 New
17,066 $114,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.